The Cures Act helps bring our healthcare innovation infrastructure into the 21st Century and pave the way for more breakthrough treatments and cures. President Trump’s administration is in the process of implementing the Cures Act and more announcements about its implementation are expected later in 2017.
However, we must continue to push medical progress forward in both the public and private sectors. Biomedical research of diseases that represent more than 80 percent of all U.S. deaths receives less than half of its funding from the NIH, according to 2015 research from the University of Rochester Medical Center that appeared in the Journal of the American Medical Association. The authors also found that the allocation of research resources does not reflect the burden of disease on society.
“Medical innovation offers many life-saving and economic benefits,” says Cardinal Health Chief Medical Officer Shaden Marzouk. “The 21st Century Cures Act is a much-needed step forward for medical progress, but we must maintain and strengthen our collective commitment to the necessary work of discovering, developing and delivering new treatments and cures in our rapidly-changing healthcare landscape.”